Shares of HCP Inc. (NYSE:HCP) traded down 1.6% on Thursday . The company traded as low as $36.66 and last traded at $36.82, with a volume of 1,367,605 shares changing hands. The stock had previously closed at $37.43.

A number of analysts have weighed in on the stock. Zacks Investment Research downgraded shares of HCP from a “hold” rating to a “strong sell” rating in a report on Monday, May 2nd. Jefferies Group upgraded shares of HCP from an “underperform” rating to a “hold” rating and lifted their price target for the stock from $25.00 to $32.00 in a research report on Tuesday, May 10th. BMO Capital Markets reiterated a “sell” rating on shares of HCP in a research report on Monday, June 20th. Goldman Sachs Group Inc. upgraded shares of HCP from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $26.00 to $36.00 in a research report on Friday, July 8th. Finally, Barclays PLC cut shares of HCP from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $40.00 to $37.00 in a research report on Wednesday, June 1st. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $33.97.

The company’s market cap is $17.48 billion. The company’s 50-day moving average is $34.87 and its 200-day moving average is $33.84.

HCP (NYSE:HCP) last posted its quarterly earnings results on Monday, May 9th. The real estate investment trust reported $0.69 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.69. The business had revenue of $640.80 million for the quarter, compared to the consensus estimate of $621.93 million. HCP’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.79 earnings per share. Analysts predict that HCP Inc. will post $2.78 EPS for the current year.

Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of HCP by 3.1% in the fourth quarter. Vanguard Group Inc. now owns 61,238,590 shares of the real estate investment trust’s stock worth $2,341,765,000 after buying an additional 1,813,634 shares in the last quarter. Agran Libbie boosted its position in shares of HCP by 10,073.6% in the fourth quarter. Agran Libbie now owns 24,472,696 shares of the real estate investment trust’s stock worth $9,358,000 after buying an additional 24,232,146 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of HCP by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 5,839,233 shares of the real estate investment trust’s stock worth $223,297,000 after buying an additional 78,249 shares in the last quarter. New York State Common Retirement Fund boosted its position in shares of HCP by 0.4% in the fourth quarter. New York State Common Retirement Fund now owns 1,072,700 shares of the real estate investment trust’s stock worth $41,020,000 after buying an additional 4,300 shares in the last quarter. Finally, BHF Kleinwort Benson Group S.A. boosted its position in shares of HCP by 10.4% in the fourth quarter. BHF Kleinwort Benson Group S.A. now owns 960,195 shares of the real estate investment trust’s stock worth $36,718,000 after buying an additional 90,324 shares in the last quarter.

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.